Mobidiag: Hologic Strengthens Diagnostics Business With $795M Mobidiag Deal

Hologic Inc (NASDAQ: HOLX) has agreed to acquire Mobidiag Oy, a privately held, Europe-based provider of molecular diagnostic tests and instrumentation, for an enterprise value of approximately $795 million. The deal includes a cash payment of approximately $714 million (€600 million) for Mobidiag's equity and net debt of roughly $81 million. Mobidiag develops and markets PCR ...Full story available on Benzinga.com